May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Purification of Autologous Plasmin for Vitreoretinal Surgery
Author Affiliations & Notes
  • T. Sakuma
    Juntendo Urayasu Hospital, Urayasu, Japan
  • J. Inoue
    Juntendo Urayasu Hospital, Urayasu, Japan
  • M. Kiyokawa
    Juntendo Urayasu Hospital, Urayasu, Japan
  • N. Hatano
    Juntendo Urayasu Hospital, Urayasu, Japan
  • Y. Tamiya
    Juntendo Urayasu Hospital, Urayasu, Japan
  • K. Shiina
    Juntendo Urayasu Hospital, Urayasu, Japan
  • A. Mizota
    Juntendo Urayasu Hospital, Urayasu, Japan
  • M. Tanaka
    Juntendo Urayasu Hospital, Urayasu, Japan
  • Footnotes
    Commercial Relationships  T. Sakuma, None; J. Inoue, None; M. Kiyokawa, None; N. Hatano, None; Y. Tamiya, None; K. Shiina, None; A. Mizota, None; M. Tanaka, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4684. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Sakuma, J. Inoue, M. Kiyokawa, N. Hatano, Y. Tamiya, K. Shiina, A. Mizota, M. Tanaka; Purification of Autologous Plasmin for Vitreoretinal Surgery . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4684.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Plasmin purified from autologous blood is a useful enzyme for vitreoretinal surgery, but it requires a long and difficult time to isolate. The purpose of this study was to develop an improved method to obtain safe and highly–purified autologous plasmin in a shorter time for use as an adjunct to vitreoretinal surgery.

Methods: : To isolate plasmin, the proteinase inhibitors, aprotinin and benzamidine, were used to suppress protein denaturation. The collected blood (30 ml) was centrifuged and 10 ml of plasma was used. The plasma was injected into a previously activated lysine affinity cartridge. The affinity cartridge was washed with 10 ml of 50 mM potassium phosphate buffer at pH 7.5 to remove any unbound plasma proteins. The bound plasminogen was eluted from the cartridge with 2.5 mM epsilon aminocaproic acid, and the epsilon aminocapric was subsequently removed by a concentration kit. The concentrated plasminogen was passed through a 0.22 micron filter into a sterile vial. The samples were incubated for 48 hours to check for contamination. Plasminogen was converted to plasmin by adding 500 units of urokinase. The activity of the activated plasmin was checked before use.

Results: : By adding the suppressors of protein denaturation in the purification process, high–purity plasmin can be prepared from autologous blood in a shorter time. The 10 ml of plasma provided a dose of approximately 1 unit in a volume of 0.1 ml. No bacterial contamination was detected.

Conclusions: : Our new method allows us to isolate autologous plasmin safely, easily, and in a shorter time. This method should expand the use of plasmin in the clinic

Keywords: vitreoretinal surgery • enzymes/enzyme inhibitors • vitreous 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×